Literature DB >> 32838408

Prevalence and genotype distribution of human papillomavirus infection in Huzhou City, eastern China, 2018-2019.

Yurong Zhu1, Fuchu Qian2,3, Weihua Zou4, Xiaoyun Wu1, Chunlin Liu1, Guosong Shen5, Shiping Lai6, Sheng Yang1.   

Abstract

BACKGROUND: Human papillomavirus (HPV) infection is involved in cervical cancer development, and hence understanding its prevalence and genotype distribution is important. However, there are few reports on the prevalence and genotype distribution of HPV in the city of Huzhou in China.
METHODS: In this retrospective cross-sectional study, 11,506 women who visited Huzhou Maternity & Child Health Care Hospital between January 2018 and October 2019 were enrolled. The results of HPV genotyping and cytology tests were analyzed.
RESULTS: The overall prevalence of HPV infection was 15.5%. The rate of high-risk (HR) HPV infection (13.5%) was higher than that of single low-risk (LR) HPV infection (2.0%) (p<0.05). The five most common HPV genotypes were HPV52 (3.3%), 16 (1.9%), 58 (1.7%), 53 (1.5%), and 81 (1.2%). The infection rate of HPV peaked in women aged 16-24 and women aged ≥55. The infection rate of HPV58 or HPV81 appeared as a single peak in women aged ≥55. The rates of HR-HPV and LR-HPV infection were higher in subjects with abnormal cytology (p<0.05).
CONCLUSIONS: HPV infection is high in Huzhou, and HPV53 and HPV81 are the prevalent genotypes. HPV infection rate is associated with age and cytology. Regional HPV surveillance is essential to optimize current HPV prevention and vaccine development.
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  China; genotype; human papillomavirus; prevalence

Mesh:

Year:  2021        PMID: 32838408     DOI: 10.1093/trstmh/traa077

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort.

Authors:  Zhi-Fang Li; Xin-Hua Jia; Xiangxian Feng; Shaokai Zhang; Xun Zhang; Qin-Jing Pan; Xun-Wen Zou; Yue-Qing Hao; Xi-Bin Sun; You-Lin Qiao
Journal:  BMJ Open       Date:  2022-10-17       Impact factor: 3.006

2.  Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.

Authors:  Fangfang Zhong; Ting Yu; Xiaoxi Ma; Shunni Wang; Qing Cong; Xiang Tao
Journal:  Dis Markers       Date:  2022-06-10       Impact factor: 3.464

3.  Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.

Authors:  Xiuli Wang; Shuizhong Han; Xingwei Li; Xiaochuan Wang; Shan Wang; Li Ma
Journal:  Virol J       Date:  2022-03-04       Impact factor: 4.099

4.  The prevalence and genotype distribution of human papillomavirus among women in Guangxi, southern China.

Authors:  Liuting Wei; Liping Ma; Lingyan Qin; Zhihu Huang
Journal:  Infect Agent Cancer       Date:  2022-04-21       Impact factor: 2.965

5.  Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China.

Authors:  Xiaoxiao Li; Fenfen Xiang; Junhua Dai; Tao Zhang; Zixi Chen; Mengzhe Zhang; Rong Wu; Xiangdong Kang
Journal:  Virol J       Date:  2022-09-12       Impact factor: 5.913

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.